Based on the scaffolds of caffeic acid phenethyl ester (CAPE) as well as bioactive lactone-containing compounds, 6-acrylic phenethyl ester-2-pyranone derivatives were synthesized and evaluated against five tumor cell lines (HeLa, C6, MCF-7, A549, and HSC-2). Most of the new derivatives exhibited moderate to potent cytotoxic activity.
Please note that technical editing may introduce minor changes to the text and/or graphics, which may alter content. The journal's standard Terms & Conditions and the Ethical guidelines still apply. In no event shall the Royal Society of Chemistry be held responsible for any errors or omissions in this Accepted Manuscript or any consequences arising from the use of any information it contains.
Accepted Manuscript
Organic & Biomolecular Chemistry www.rsc.org/obc cytotoxic activity of CAPE and related derivatives. Our plan was to change the catechol ring to a lactone ring, specifically a 4-methoxy-2H-pyran-2-one. Lactone ring systems are found in many bioactive natural products obtained from plants, animals, marine organisms, bacteria, and insects, 10 including those that exhibit various pharmacological activities, such as HIV protease inhibitory, 11 anticonvulsant, 12 antimicrobial, 13 antitumor, 14, 15 and other effects. Examples include styryl-2-pyrone, 16 isorumbrin, 17 bufadienolide, 18 neo-tanshinlactone, 19 wortmannin, 20 and camptothecin, 21 as shown in Figure 2 . Based on numerous modification studies, such as those performed on camptothecin and its derivatives, a lactone ring can be an important pharmacophore in anticancer drugs. Therefore, based on the antitumor activity of CAPE and various lactone-containing compounds, we combined both CAPE and styryl-2-pyrone scaffolds as chemical starting points to design chemically modified CAPE analogues, which contain variously substituted acrylic phenethyl esters and a 4-methyoxy-2-pyranone moiety
Since the lactone ring in the target compound was not stable in strong basic solution,
we had explored several bases, such as K 2 CO 3 , Et 3 N, EtONa, and piperidine. As a result, piperidine was the best. To discover the best solvent, we had explored methanol, ethanol, and pyridine. Pyridine was the commonly used solvent for
Knoevenagel condensation, and we found it was also the best solvent to afford our desired compound 4. The reaction temperature was also optimized. Room temperature, 60 o C, and reflux temperature were investigated, and we found reflux reaction temperature was the best. So we chose piperidine as the base, pyridine as the solvent, and the reaction temperature was at reflux. Finally, our desired series-5 compounds were prepared from 4 through an esterification reaction using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC·HCl) as a condensing reagent. The obtained yields were varied from 49% to 71%. 
Antitumor activity against five human cancer cell lines
To evaluate the effects of 5-derivativeson the growth of human cancer cells, the growth inhibitory potential was evaluated using a MTT assay in five human cancer cells. Initially, 12 compounds (5a-l) were screened at 20 μM. Only compounds 5b and 5e exhibited significant in vitro antitumor activity (greater than 50% growth inhibition) against the tested human cancer cell lines at this concentration. Table 1 lists the IC 50 values for the active compounds. Interestingly, both 5b and 5e were substituted at C-2 of the benzene ring, while the inactive compounds (5a, 5c, 5e, 5f, and 5g) were substituted at the C-3 or C-4 position or contained a heterocyclic rather than benzene ring (5h-l). While substitution at C-2 sharply affected the antitumor activity, both chlorine and methyl groups had similar impacts (compare 5b vs 5e). Moreover, both new lactone-containing CAPE-derivatives were more active than CAPE, especially against MCF-7, HSC-2, and HeLa cancer cell lines. 
On the basis of the preliminary results, nine additional 5-derivatives were synthesized to more fully evaluate the effects of substituents at C-2 on the cytotoxicity.
Compounds 5m-u contained-F, -Br, -OCH 3 , -CF 3 , and -NO 2 substituents, as well as multiply substituted phenyl rings or a naphthyl ring. The assay results are shown in Table 2 . Compounds with a 2-F or 2-NO 2 group (5m and 5r, respectively) were inactive against all cancer cell lines, whereas the derivative with a 2-Br group (5n) was active against four cell lines. These results demonstrated that stronger electron-withdrawing inductive effects decreased the antitumor activity. Compounds with a 2-methoxy (5p) or 2-trifluoromethyl (5q) group were active only against the HeLa cell lines, which appeared to have the greatest sensitivity to this compound class.
Among the compounds with multiple substituents on the phenyl ring, the 2,4,6-trimethylated compound (5t) showed significant activity against the MCF-7, Fig.3 . Cells treated with 5o (0.5 and 1 μM) displayed morphological changes and showed distinctly rounded shapes compared with the control cells (Fig.3B ). This result prompted us to study the mechanism of action of 5o
in HeLa cell lines. 
Cell cycle effects of 5o
Based on previous investigation, cell proliferation is associated with regulation of three phases (G0/G1, S, and G2/M) of the cell cycle. To investigate if growth treatment with 5o for 48 h significantly increased the level of cleaved caspase-3
(active form of caspase-3) in a dose-dependent manner compared with control group.
At the same time, total full-length PARP (116 kDa) was cleaved to large fragment (89 kDa), and cleaved PARP also increased remarkably in a dose-dependent manner.
These findings corresponded with the activation of caspase-3 and the data demonstrated that 5o induced HeLa cell apoptosis through activation of the caspase-mediated pathway. 
5o induced morphological changes by actin cytoskeleton disruption
As shown in Fig.3B , significant changes in cell morphology were observed. HeLa cells treated with 5o (0.5 and 1 μM) for 24 h exhibited distinctly round shape and detachment compared to the untreated cells. Cell morphology and adhesion are usually associated with the actin cytoskeleton. 31 Therefore, immunofluorescence microscopy was used to explore the effect of 5o on actin cytoskeleton. In the control group, actin was diffusely distributed, whereas in the 5o-treated group (0.5 μM), actin was locally clustered. When HeLa cells were treated with 1 μM of 5o, actin aggregation was enhanced and actin disruption was also generated (Fig.6 ).
Additionally, apoptotic bodies (denoted by red mark), which are consistent with apoptosis-induced conclusion, were observed in HeLa cells treated with 1 μM of 5o.
These results suggested that 5o induced actin aggregation and further disrupted the actin cytoskeleton. Because a disequilibrium of the actin dynamics between G-actin and F-actin can result in actin aggregation and influence cell shape and cell adhesion, 32 we speculated that 5o induced actin aggregation and actin cytoskeleton disruption through disturbing the actin dynamic equilibrium. Actin dynamics is essential to cell division. G2/M-phase blockage of 5o may also contribute to the abnormal actin dynamics, but the detailed mechanism should be further confirmed. 
Inhibition of cell migration and invasion
Malignant tumor invasion and metastasis have been hot and difficult research topics in oncology. Tumor cells use their intrinsic migratory ability to invade adjacent tissues and the vasculature and, ultimately, to metastasize. 33 Migration and invasion of cancer cells is dependent on the actin cytoskeleton, 34 which is driven by the polymerization of actin within two distinct structures, lamellipodia and filopodia, and attachment to the extracellular matrix through actin-rich adhesive structures. 35 In previous confocal assays, we observed that the 5o disturbed the actin dynamics and disrupted the actin cytoskeleton. Subsequently, we conducted invasion and migration assays to explore whether 5o influenced the migration and invasion abilities of HeLa cells. In Migration potential is without matrigel. These images show the number of HeLacells passing through the filter with/without matrigel. As the 5o dose increased, the number of cells on the undersurface of the filter decreased.
Preliminary ADMET Study
To investigate the drug-like profiles of the synthesized compounds, we submitted several 5-series compound for preliminary ADMET prediction (Table 3) . Improved blood brain barrier penetration (BBB) and decreased liver toxicity were calculated for 5o in comparison with CAPE. In addition, calculations indicated that 5o had good absorption and solubility and could easily be bound to carrier proteins in the blood,
while showing no inhibition of CYP2D6. However, 5o should still be evaluated experimentally and further optimized regarding its pharmacokinetics properties. predicts CYP2D6 enzyme inhibition using 2D chemical structure. 0 (Non-inhibitor); f PPB predicts whether a compound is likely to be highly bound to carrier proteins in the blood. 1 (binding ability > 90%), 2 (binding ability > 95%).
Conclusion
In summary, the acrylic phenethyl ester portion of CAPE was combined with the 4-methoxy-2H-pyran-2-one of styryl-2-pyrone, and a series of 6-acrylic phenethyl ester-2-pyranone derivatives were designed and synthesized. Among the new compounds, 5o exhibited significantly more anti-proliferation activity than CAPE against five human cancer cell lines. Particular efficacy was observed against the 
Synthesis of (E)-3-(4-methoxy-2-oxo-2H-pyran-6-yl) acrylic acid (4) 36
A solution of aldehyde (3) (3.08 g, 20 .0 mmol), malonic acid (2.08 g, 20 .0 mmol) in pyridine (10 ml, 120 mmol) and piperidine (0.1 ml) was heated to reflux for 3 h. The 
Synthesis of (E)-2-chlorophenethyl-3-(4-methoxy-2-oxo-2H-pyran-6-yl) acrylate (5b)
Following the general procedure, 5b was obtained as a white solid (68.1 mg, 68 %). 
Synthesis of (E)-3-chlorophenethyl-3-(4-methoxy-2-oxo-2H-pyran-6-yl) acrylate (5c)
Following the general procedure, 5c was obtained as a white solid (52.1 mg, 52 %). 
Synthesis of (E)-4-chlorophenethyl-3-(4-methoxy-2-oxo-2H-pyran-6-yl) acrylate (5d)
Following the general procedure, 5d was obtained as a white solid (65.1 mg, 65 %). 
Synthesis of (E)-2-methylphenethyl-3-(4-methoxy-2-oxo-2H-pyran-6-yl) acrylate (5e)
Following the general procedure, 5e was obtained as a white solid (51.8 mg, 55 %). 9, 165.6, 162.8, 155.7, 136.4, 135.6, 133.8, 130.4, 129.6, 126.8, 126.1, 124.5, 106.1, 91.4, 64.7, 56.1, 32.3, 19.3 
Synthesis of (E)-3-methylphenethyl-3-(4-methoxy-2-oxo-2H-pyran-6-yl) acrylate (5f)
Following the general procedure, 5f was obtained as a white solid (52.8 mg, 56 %).
δ C 169.9, 165. 6, 162.8, 155.7, 138.1, 137.5, 133.8, 129.7, 128.4, 127.4, 125.9, 124.6, 106.1, 91.3, 65.7, 56.1, 35.0, 21.3 6, 162.8, 158.4, 155.7, 133.8, 129.9, 129.6, 124.6, 114.0, 106.1, 91.3, 65.8, 56 
Synthesis of (E)-2-(piperidin-1-yl)ethyl-3-(4-methoxy-2-oxo-2H-pyran-6-yl) acrylate (5h)
Following the general procedure, 5h was obtained as a white solid (50.0 mg, 51 %). 9, 165.6, 162.8, 155.7, 133.8, 124.6, 106.1, 91.3, 62.9, 57.2, 56.1, 54.8, 25.9, 24.1; MS (ESI) : m/z 308.1 [M+H] + .
Synthesis of (E)-2-(pyridin-2-yl)ethyl-3-(4-methoxy-2-oxo-2H-pyran-6-yl) acrylate (5i)
136. 5, 133.8, 124.4, 123.5, 121.7, 106.1, 91.3, 64.2, 56.2, 37.3 
Synthesis of (E)-2-morpholinoethyl-3-(4-methoxy-2-oxo-2H-pyran-6-yl) acrylate (5j)
Following the general procedure, 5j was obtained as a white solid (52.9 mg, 57 %). 9, 165.6, 162.7, 155.6, 134.0, 124.4, 106.2, 91.4, 66.8, 62.3, 57.0, 56.2, 53.8 
Synthesis of (E)-2-(thiophen-2-yl)ethyl-3-(4-methoxy-2-oxo-2H-pyran-6-yl) acrylate (5k)
Following the general procedure, 5k was obtained as a white solid (63.4 mg, 69 %). 5, 162.7, 155.6, 139.6, 134.0, 126.9, 125.6, 124.4, 124.1, 106.2, 91.4 
Synthesis of (E)-2-(4-methylthiazol-5-yl)ethyl-3-(4-methoxy-2-oxo-2H-pyran-6-yl) acrylate (5l)
Following the general procedure, 5l was obtained as a white solid (60.7 mg, 63 %). 9, 165.4, 162.7, 155.5, 150.0, 149.9, 134.3, 126.4, 124.0, 106.4, 91.5, 64.6, 56.2, 25.8, 14.9 
Synthesis of (E)-2-fluorophenethyl-3-(4-methoxy-2-oxo-2H-pyran-6-yl) acrylate (5m)
Following the general procedure, 5m was obtained as a white solid (60.1 mg, 63 %). 9, 165.5, 162.8, 155.6, 137.0, 133.9, 132.9, 131.2, 128.5, 127.6, 124.6, 124.3, 106.2, 91.4, 64.0, 56.2, 35.2 
Synthesis of (E)-2, 6-dichlorophenethyl-3-(4-methoxy-2-oxo-2H-pyran-6-yl) acrylate (5o)
Following the general procedure, 5o was obtained as a white solid (69.6 mg, 63 %). 9, 165.5, 162.8, 155.7, 135.9, 133.9, 133.6, 128.5, 128.3, 124.4, 106.2, 91.3, 62.6, 56.2, 30.4 0, 165.7, 162.9, 157.6, 155.7, 133.6, 130.8, 128.0, 125.8, 124.7, 120.4, 110.3, 106.0, 91.3, 64.5, 56.1, 55.2, 29.9 
Synthesis of (E)-2-(trifluoromethyl)phenethyl-3-(4-methoxy-2-oxo-2H-pyran-6-yl) acrylate (5q)
Following the general procedure, 5q was obtained as a white solid (56.3 mg, 51 %). 9, 165.5, 162.8 155.6, 136.1, 134.0, 131.8, 131.8, 128.8, 126.9, 126.2 (q, J = 5.6 Hz, 11.1 Hz), 124.3, 106.2, 91.4, 64.9, 56.2, 31.8 
Synthesis of (E)-2-nitrophenethyl-3-(4-methoxy-2-oxo-2H-pyran-6-yl) acrylate (5r)
Following the general procedure, 5r was obtained as a white solid (72.5 mg, 70 %). 
Synthesis of (E)-2-(naphthalen-1-yl)ethyl-3-(4-methoxy-2-oxo-2H-pyran-6-yl) acrylate (5u)
Following the general procedure, 5u was obtained as a white solid (60.9 mg, 58 %). 9, 165.6, 162.6, 155.6, 133.9, 133.5, 132.0, 130.9, 128.9, 127.5, 127.1, 126.2, 125.7, 125.5, 124.4, 123.5, 106.2, 91.4 
Cell culture
HeLa, HSC-2, and A549 cell lines were kindly provided by Professor Li Haiou (Japan). MCF-7 and C6 were purchased from Center of Experiment Animal of Sun Yat-sen University (Guangzhou, China). Cells were cultured in Dulbecco's modified Eagle's medium (Gibco) supplemented with 10% (v/v) fetal bovine serum (Hyclone), 100 U/mL of penicillin, and 100 μg/mL of streptomycin (Hyclone). These cells were grown in a humidified incubator containing 5% CO 2 at 37 o C and subcultured every three days.
Antiproliferative Assays
These derivatives were evaluated for their antiproliferative activity in five different 
Migration and invasion assay
The vitro migration and invasion assays were carried out using 24-well plates with 8-μm pore size inserts (Transwell, Corning, USA). Only for the invasion assay, the upper chamber was coated with 100 μL diluted matrigel (0.5 mg/mL). Serum-free DMEM cells suspension (100 μL, 3 ×10 5 cells/mL) with/without 5o (0.5, 1 μM) was added in the upper chamber. Medium (600 μL) with 10% FBS was added to the lower chamber. After 36 h of incubation, cells were fixed with 4% formaldehyde and stained with 0.1% crystal violet. Then, cells on the upper membrane surface were 2D6 inhibition, hepatotoxicity, human intestinal absorption (HIA) and plasma protein binding of a set of compounds.
